197 results Mari Muzashvili Junior Associate Brussels Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Anya Murphy Junior Associate Brussels Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Stibbe represents HEMA’s management board Stibbe represented HEMA’s management board in summary proceedings brought by a noteholder seeking to block the implementation of HEMA’s envisaged restructuring. Stibbe represents the bankruptcy trustees of Amsterdam hospital MC Slotervaart in dispute with the City of Amsterdam Stibbe represented the bankruptcy trustees of the Amsterdam hospital MC Slotervaart in proceedings against the City of Amsterdam, centred on the City’s demand that the bankruptcy trustees investigate whether there were any irregularities prior to the ban Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Corporate Recovery & Insolvency in the Netherlands Does the legislative framework in your jurisdiction allow for informal work-outs, as well as formal restructuring and insolvency proceedings, and to what extent are each of these used in practice? What formal rescue procedures are available in your jurisd Daisy Nijkamp Partner Amsterdam Over fixatie en verificatie van vorderingen Gertjan Boekraad schreef een artikel in het Tijdschrift voor Insolventierecht over een arrest van de Hoge Raad van 23 maart 2018 waarin het criterium voor de verifieerbaarheid van vorderingen in faillissement is aangescherpt. 15 aspects of Brexit you did not know A Brexit without a deal, or with a deal that does not cover all relevant aspects, is still a potential scenario. We have highlighted a number of unexpected legal consequences of Brexit in such a no deal or incomplete deal scenario. Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland). Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Stibbe advises Frigoglass Stibbe advises Frigoglass on the completion of its restructuring proces Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises Nyobe NV Stibbe assisted Nyobe NV with its judicial reorganisation procedure with a view of transferring Nyobe’s activities under the court’s supervision, after Nyobe was confronted with a fiscal claim of 100 million euro. Pagination Previous page Page 5 Current page 6 Page 7 Page 8 Next page
Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.
Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.
Stibbe represents HEMA’s management board Stibbe represented HEMA’s management board in summary proceedings brought by a noteholder seeking to block the implementation of HEMA’s envisaged restructuring.
Stibbe represents the bankruptcy trustees of Amsterdam hospital MC Slotervaart in dispute with the City of Amsterdam Stibbe represented the bankruptcy trustees of the Amsterdam hospital MC Slotervaart in proceedings against the City of Amsterdam, centred on the City’s demand that the bankruptcy trustees investigate whether there were any irregularities prior to the ban
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Corporate Recovery & Insolvency in the Netherlands Does the legislative framework in your jurisdiction allow for informal work-outs, as well as formal restructuring and insolvency proceedings, and to what extent are each of these used in practice? What formal rescue procedures are available in your jurisd
Over fixatie en verificatie van vorderingen Gertjan Boekraad schreef een artikel in het Tijdschrift voor Insolventierecht over een arrest van de Hoge Raad van 23 maart 2018 waarin het criterium voor de verifieerbaarheid van vorderingen in faillissement is aangescherpt.
15 aspects of Brexit you did not know A Brexit without a deal, or with a deal that does not cover all relevant aspects, is still a potential scenario. We have highlighted a number of unexpected legal consequences of Brexit in such a no deal or incomplete deal scenario.
Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland).
Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.
Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises Nyobe NV Stibbe assisted Nyobe NV with its judicial reorganisation procedure with a view of transferring Nyobe’s activities under the court’s supervision, after Nyobe was confronted with a fiscal claim of 100 million euro.